VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-23.53%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$180M
AUM Growth
+$180M
(-44%)
Cap. Flow
-$43.8M
Cap. Flow
% of AUM
-24.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Ventyx Biosciences
VTYX
|
$39M |
| 2 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$4.71M |
| 3 |
Pharvaris
PHVS
|
$146K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ventyx Biosciences
VTYX
$171M
| $77M | 42.68% | 2,298,833 -1,162,703 | -34% | -$39M |
|
2
ALX Oncology
ALXO
$62.7M
| $43.8M | 24.3% | 9,699,925 | – | – |
|
3
Harmony Biosciences
HRMY
$2.12B
| $33.8M | 18.74% | 1,035,396 | – | – |
|
|
4
Pharvaris
PHVS
$1.39B
| $18.4M | 10.17% | 2,278,575 -18,135 | -0.8% | -$146K |
|
|
IMPL
5
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $3.86M | 2.14% | 2,759,791 | – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $3.55M | 1.97% | 1,866,339 | – | – |
|
|
CINC
7
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| – | – | -383,390 | Closed | -$4.71M |
|